Envestnet Portfolio Solutions Inc. Has $274,000 Stock Holdings in Avantor, Inc. (NYSE:AVTR)

Envestnet Portfolio Solutions Inc. lowered its stake in Avantor, Inc. (NYSE:AVTR - Free Report) by 57.4% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 16,901 shares of the company's stock after selling 22,804 shares during the period. Envestnet Portfolio Solutions Inc.'s holdings in Avantor were worth $274,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in AVTR. State of Alaska Department of Revenue raised its position in shares of Avantor by 2.8% during the first quarter. State of Alaska Department of Revenue now owns 79,797 shares of the company's stock worth $1,293,000 after acquiring an additional 2,200 shares during the last quarter. Dynamic Advisor Solutions LLC increased its position in Avantor by 43.9% during the 1st quarter. Dynamic Advisor Solutions LLC now owns 34,186 shares of the company's stock valued at $554,000 after purchasing an additional 10,433 shares during the period. Salem Investment Counselors Inc. raised its holdings in Avantor by 15.9% during the 1st quarter. Salem Investment Counselors Inc. now owns 89,667 shares of the company's stock worth $1,454,000 after purchasing an additional 12,285 shares during the last quarter. Fifth Third Bancorp boosted its stake in Avantor by 52.0% during the first quarter. Fifth Third Bancorp now owns 3,972 shares of the company's stock worth $64,000 after acquiring an additional 1,359 shares in the last quarter. Finally, Assenagon Asset Management S.A. grew its holdings in Avantor by 5.8% in the first quarter. Assenagon Asset Management S.A. now owns 38,285 shares of the company's stock worth $621,000 after purchasing an additional 2,108 shares during the period. 95.08% of the stock is owned by institutional investors and hedge funds.

Avantor Price Performance

Shares of NYSE AVTR opened at $13.55 on Monday. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.75 and a current ratio of 1.12. The stock has a market cap of $9.23 billion, a PE ratio of 13.03, a price-to-earnings-growth ratio of 1.44 and a beta of 1.04. Avantor, Inc. has a fifty-two week low of $11.82 and a fifty-two week high of $28.00. The stock has a fifty day moving average of $13.23 and a 200-day moving average of $16.82.

Avantor (NYSE:AVTR - Get Free Report) last released its quarterly earnings results on Friday, April 25th. The company reported $0.23 earnings per share for the quarter, meeting the consensus estimate of $0.23. The firm had revenue of $1.58 billion for the quarter, compared to analysts' expectations of $1.61 billion. Avantor had a return on equity of 11.93% and a net margin of 10.70%. The company's revenue was down 5.9% compared to the same quarter last year. During the same quarter last year, the firm posted $0.22 EPS. Equities research analysts anticipate that Avantor, Inc. will post 1.06 earnings per share for the current year.

Insider Activity at Avantor

In other news, Director Joseph R. Massaro bought 8,100 shares of Avantor stock in a transaction that occurred on Tuesday, April 29th. The shares were acquired at an average price of $12.30 per share, with a total value of $99,630.00. Following the completion of the purchase, the director now directly owns 35,038 shares in the company, valued at $430,967.40. The trade was a 30.07% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Gregory L. Summe acquired 20,000 shares of the business's stock in a transaction dated Thursday, May 22nd. The stock was purchased at an average price of $12.65 per share, with a total value of $253,000.00. Following the completion of the acquisition, the director now directly owns 70,000 shares in the company, valued at approximately $885,500. This represents a 40.00% increase in their position. The disclosure for this purchase can be found here. Insiders have purchased 83,100 shares of company stock valued at $1,027,630 over the last three months. 1.20% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on AVTR. Stifel Nicolaus cut Avantor from a "buy" rating to a "hold" rating and cut their target price for the stock from $26.00 to $14.00 in a report on Monday, April 28th. Robert W. Baird reduced their price objective on shares of Avantor from $21.00 to $17.00 and set an "outperform" rating for the company in a report on Monday, April 28th. TD Cowen cut shares of Avantor from a "buy" rating to a "hold" rating and set a $15.50 price target on the stock. in a research report on Monday, April 28th. Barclays dropped their price objective on Avantor from $18.00 to $15.00 and set an "overweight" rating on the stock in a research note on Monday, April 28th. Finally, Royal Bank Of Canada lowered their target price on shares of Avantor from $24.00 to $20.00 and set an "outperform" rating for the company in a report on Monday, April 28th. Seven investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus target price of $18.88.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.